Seth A. Lemings

Practice Details

• Firm Information
  Position

  Associate

  Firm Name

  Sheppard Mullin
• Representative Cases & Transactions
  Cases

  Experience: Offerings: Represented GAN Limited in its initial public offering
  secondary public offering.
  Represented Kiromic BioPharma, Inc., RenovoRx, Inc.,
  Unicycive Therapeutics, Inc. in their initial public offerings.
  Represented underwriter in connection with initial public offering
  listing of issuer on Nasdaq in Q4 2021.
  Represented various other issuers
  underwriters in public offerings
  private placements across multiple industries.
  Representing foreign issuer (Technology Company) in connection with its proposed initial public offering
  listing on NYSE in Q1 2024.
  Representing underwriter in connection with proposed initial public offering
  listing on NYSE in 2024 (Medical Device Company).
  SPACs: Represented Goal Acquisition Corp. in its public company reporting matters in anticipation of a de-SPAC transaction, including SEC
  Nasdaq compliance
  reporting.
  Represented OPAL Fuels Inc., a leading producer
  distributor of low-carbon intensity renewable natural gas, in its public offerings
  reporting matters subsequent to its successful go-public transaction via de-SPAC.
  Other Transactions: Represented LKQ Corp. (Nasdaq: LKQ) in a 144A offering of senior unsecured notes in the aggregate principal amount of $1.4 billion.